Christopher Cano's most recent trade in Tff Pharmaceuticals Inc was a trade of 43,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 22, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tff Pharmaceuticals Inc | Christopher Cano | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2021 | 43,000 | 200,000 | - | - | Stock Option (Right to Buy) |